Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-10-24 Bolzon Bradley J PhD Director Conversion +73,704 73,704
2016-10-24 Bolzon Bradley J PhD Director Conversion +5,774 79,478
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series A-1 Preferred Shares −437,247 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series A-1 Preferred Shares −2,754 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series A-2 Preferred Shares −3,100,477 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series A-2 Preferred Shares −19,524 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series A-3 Preferred Shares −2,210,417 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series A-3 Preferred Shares −66,490 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series A-3 Preferred Shares −168,224 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series A-3 Preferred Shares −73,704 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series B Preferred Shares −231,077 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series B Preferred Shares −1,454 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series B Preferred Shares −173,167 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series B Preferred Shares −5,210 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series B Preferred Shares −13,180 0
2016-10-24 Bolzon Bradley J PhD Director Conversion · Series B Preferred Shares −5,774 0
2016-10-24 CELGENE CORP /DE/ 10% owner Conversion +4,034,830 4,034,830
2016-10-24 CELGENE CORP /DE/ 10% owner Purchase +800,150 $14.00 $11.2M 4,834,980
2016-10-24 CELGENE CORP /DE/ 10% owner Conversion · Series B Preferred Shares −4,034,830 0
2016-10-24 CELGENE CORP /DE/ 10% owner Conversion +4,034,830 4,034,830

Page 72 of 74 · 1,471 trades